Clariant AG (CLN) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Clariant AG stock CHF 17.12, price CHF 10.70, upside +60.0%, quality 50 out of 100. Rating: strongly undervalued. Calculated from audited financials with 13 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range CHF 6.31 – CHF 16.93 · fair‑value band CHF 10.87 – CHF 23.35 · the CHF 10.70 price screens below the CHF 17.12 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow Clariant in your weekly email
Every Wednesday you see whether Clariant is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Clariant AG develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific. It operates through Care Chemicals, Catalysts, and Adsorbents & Additives segments.
Show moreShow less
The Care Chemicals segment offers personal and home care, crop solutions, industrial applications, base chemicals, oil services, and mining solutions for various applications in home and personal care, coatings, adhesives, and agriculture, and food.
The Catalysis segment provides business services for propylene and ethylene, syngas and fuels, and specialties.
The Adsorbents & Additives segment provides coatings, adhesives and polymer solutions for home care, personal care, coatings, adhesives, agriculture, food, electrics, electronics, automotive, oil, building, construction, aviation, and mining.
The company was founded in 1886 and is headquartered in Muttenz, Switzerland.
Stock analysis
Clariant AG (CLN) currently trades at CHF 10.70, while our model-based Fair Value estimate is CHF 17.12, implying the stock looks roughly 38% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of CHF 17.02 per share, and 9 of the 13 models we run sit above the CHF 10.70 price.
Bear case: the Earnings-Based group reads lowest at CHF 7.97, and 4 of the 13 models stay below the price. Data coverage for this calculation is medium.
Scenario range: CHF 10.87 (bear) to CHF 23.35 (bull), the price of CHF 10.70 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 50/100 (solid quality), in the Basic Materials sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Clariant AG reported revenue of CHF 3.9B in FY2025 versus CHF 4.4B in FY2021, a compound −2.7%/yr. Reported net income was −CHF 75.0M in FY2025.
Key figures
Market cap CHF 3.5B Mid · P/S ratio 0.89 · EPS (TTM) CHF −0.1000 · Dividend yield 3.9% · Net margin −0.8% · Return on equity 0.0% · Return on assets (EBIT) 5.3% (5-year average) · Operating margin 10.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).
What moves the price
The share trades about 2% below its 52-week high and 70% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at 60%, CLN screens cheaper than that median.
Fair Value models
BearCHF 10.87Fair Value CHF 17.12BullCHF 23.35
Price CHF 10.70 · Upside +60.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCFCHF 12.29CHF 19.14CHF 32.5578
Growth DCFCHF 13.13CHF 19.86CHF 32.0577
5Y EBITDA ExitCHF 10.38CHF 16.66CHF 25.0074
All 13 models by family
DCF Models
FCF DCFCHF 12.29CHF 19.14CHF 32.5578
5Y Revenue ExitCHF 8.73CHF 13.82CHF 21.2072
5Y EBITDA ExitCHF 10.38CHF 16.66CHF 25.0074
10Y Revenue ExitCHF 9.62CHF 13.64CHF 17.8967
10Y EBITDA ExitCHF 10.96CHF 15.45CHF 20.1969
Earnings-Based
EPVCHF 6.23CHF 7.97CHF 9.5374
Multiples
EV/EBITCHF 7.38CHF 11.62CHF 15.8564
EV/EBITDACHF 9.50CHF 14.44CHF 19.3866
EV/RevenueCHF 5.69CHF 10.41CHF 15.1252
Asset-Based
NCAV (Graham)CHF 0.8500CHF 1.13CHF 1.6954
Growth DCF
Growth DCFCHF 13.13CHF 19.86CHF 32.0577
Rev-Margin DCFCHF 8.73CHF 14.17CHF 20.9072
Economic Profit
ROIC CompounderCHF 6.23CHF 8.24CHF 10.5772
The fair value above starts from this blend and is adjusted for a cyclical trough year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.24/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
−5.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.3%
Start year 2020 (pandemic). Over 10 years: −3.9% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
7.7% (2020) → 10.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+6.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+2.2%
Yearly sales growth analysts expect, extended to five years.
After inflation (Switzerland: IMF forecast 0.6% a year to 2030, 0.8% from 2016 to 2025) that is about +5.5% a year for the price and +1.5% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (98 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Positive
Recent news coverage is more positive than average.
AI conclusion: Limited evidence of a durable moat emerges from thin public signals and negative profitability metrics, while the main weakness remains the gap between operating cash flow and net income alongside negative net income and ROE.
Main risk: Mixed results across the three business units risk undermining operational resilience in volatile specialty chemical segments and pressuring margins.
Clariant has realized value from its minority stake in Stahl through the recent transaction closure. At a time when our models see the company as undervalued, this capital arrives against mixed results across its three business units. Will management channel it into accelerating sustainable product innovation or focus on operational resilience in volatile segments?
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 727 stocks
Beats the industry median on 7/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score50 · Below median
Fair Value upside+60.0% · Top 25%
Profitability
Return on assets−1.3% · Bottom 25%
Net margin (12 months)−0.8% · Bottom 25%
Operating margin (12 months)10.5% · Above median
Growth and dividend
Revenue growth (quarter YoY)−6.1% · Bottom 25%
Dividend yield (12 months)3.9% · Top 25%
Balance sheet
Debt / equity0.76× · Highest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/B1.75× · Pricier than median
P/S (12 months)0.93× · Cheaper than median
Price / free cash flow (fiscal year)15.1× · Cheaper than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Clariant AG Fair Value". https://www.fairvalue-calculator.com/stock/CLN
Frequently asked questions
Is Clariant AG (CLN) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of CHF 17.12 versus a price of CHF 10.70, about +60% upside (undervalued).
What is the fair value of CLN?
Our model-based fair value for Clariant AG is CHF 17.12 (as of Nov 6, 2026), built from audited fundamentals. The current price: CHF 10.70.
What is the quality score of CLN?
Clariant AG has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Clariant AG (CLN)?
Our model-based price target is the fair value of CHF 17.12 (as of Nov 6, 2026) from 13 valuation models. Cautious scenario CHF 10.87, optimistic scenario CHF 23.35. It is a calculation from audited fundamentals, not an analyst target.
What is the Clariant AG stock forecast for 2026?
Our models put fair value at CHF 17.12, about +60% upside versus a price of CHF 10.70 (undervalued). Cautious scenario CHF 10.87, optimistic scenario CHF 23.35. The calculation is refreshed regularly with new filings.
What is the revenue of Clariant AG (CLN)?
Clariant AG reported trailing-twelve-month revenue of about CHF 3.8B (latest available figure, as of Nov 6, 2026).
Does Clariant AG pay a dividend?
Clariant AG currently shows a dividend yield of 3.93% relative to its recent price (as of Nov 6, 2026).
How much is the dividend of Clariant AG (CLN) and when is the ex-dividend date?
Clariant AG pays a dividend of CHF 0.42 per share a year, a dividend yield of 3.9%. The last ex-dividend date was Jun 2, 2026. A dividend has been paid every year since 2012. Free cash flow covers the dividend 1.69 times. Our assessment: Cash covered. The dividend is fully funded by free cash flow. The payout ratio on earnings is not available for this company.
What growth is priced into Clariant AG (CLN)?
For today's price to be fair in a discounted-cash-flow model, Clariant AG would have to grow free cash flow by +6.1 % per year for five years (discount rate 8.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +0.3 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of CLN use?
Our models discount Clariant AG at 8.3 %: a base by market capitalisation (mid), damped by beta 0.48, country premium for Switzerland. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Clariant AG that is +6.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (8.3 %) and the same formula as our fair value.
How much growth has Clariant AG (CLN) delivered so far?
Over the past 5 years revenue at Clariant AG grew +0.3 % a year. The price currently implies free-cash-flow growth of +6.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Clariant AG (CLN) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into Clariant AG (+6.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Clariant AG (CLN)?
The free-cash-flow yield on the price is 6.61 %: that much free cash flow Clariant AG produces per unit of market value. When it exceeds the discount rate of our models (8.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Clariant AG (CLN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Clariant AG it is CHF 17.12 per share (as of Nov 6, 2026), against a price of CHF 10.70. It is the blended result of 13 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is Clariant AG stock overvalued or undervalued in 2026?
As of Nov 6, 2026, CLN trades below its calculated fair value: price CHF 10.70, fair value CHF 17.12, a gap of about +60% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CLN?
No. The price is what the market pays today (CHF 10.70); the fair value is what the company's own numbers justify (CHF 17.12). For Clariant AG the two are CHF 6.42 per share apart. That gap is exactly why we show both numbers side by side.
How much is Clariant AG worth?
The market values Clariant AG at about CHF 3.5B (market capitalisation, as of Nov 6, 2026). Per share that is CHF 10.70; our models calculate a fair value of CHF 17.12 per share.
What do the bullish and bearish scenarios say about CLN?
Our models span a range for Clariant AG: cautious scenario CHF 10.87, base CHF 17.12, optimistic CHF 23.35 per share (as of Nov 6, 2026, price CHF 10.70). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of CLN?
The PEG ratio of Clariant AG is 0.90 (P/E divided by earnings growth, as of Nov 6, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Clariant AG (CLN)?
Balance-sheet figures for Clariant AG (as of Nov 6, 2026): return on equity 0.0%, debt of 0.76 per unit of equity. They feed the Quality Score of 50/100, which measures business quality independently of the share price.
How far is CLN from its 52-week high?
Clariant AG trades at CHF 10.70, about 2% below its 52-week high of CHF 10.96 and 70% above the low of CHF 6.31 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of CHF 17.12 is for.
Which stocks are comparable to Clariant AG?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Clariant AG stock attractive at the current price?
The data as of Nov 6, 2026: price CHF 10.70, calculated fair value CHF 17.12 (+60%), Quality Score 50/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CLN calculated?
We run Clariant AG through 13 models from 6 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of CHF 17.12 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Clariant AG currently trades 38% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Clariant AG (CLN)?
The closing price on Nov 6, 2026 was CHF 10.70. Our model-based fair value is CHF 17.12, about +60% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Clariant AG right now?
Solid quality (50/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (CHF 10.87 to CHF 23.35) leaves room in how you read the outcome.
Where does the earnings growth of Clariant AG (CLN) come from?
Earnings per share at Clariant AG grew −1.5 % a year from 2014 to 2025. Broken into its drivers: revenue per share −4.0 %, EBIT margin −0.2 %, tax rate +1.8 %, residual (interest, one-offs) +1.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Clariant AG
How large is the market capitalisation of Clariant AG (CLN)?
The market capitalisation of Clariant AG is CHF 3.5B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Clariant AG (CLN)?
The price-to-sales ratio of Clariant AG is 0.89 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Clariant AG (CLN)?
Earnings per share at Clariant AG are CHF −0.1000. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Clariant AG (CLN)?
The dividend yield of Clariant AG is 3.9%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Clariant AG (CLN)?
The net margin of Clariant AG is −0.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Clariant AG (CLN)?
The return on equity (ROE) of Clariant AG is 0.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Clariant AG (CLN)?
On an EBIT basis the return on assets of Clariant AG is 5.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Clariant AG (CLN)?
The operating margin of Clariant AG is 10.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Clariant AG (CLN)?
Revenue at Clariant AG is growing −6.1% versus a year earlier (3y avg −9.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Clariant AG (CLN)?
Earnings per share at Clariant AG are growing +163% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Clariant AG (CLN) carry?
The net debt of Clariant AG is CHF 1.8B (fiscal year 2025, ≈ 7.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Clariant AG in the live analysis
One click puts Clariant AG on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 6, 2026